Milos Graonic, senior vice president, global leader of Nielsen BASES Pharmaceutical Practice, on how to mine patient data for forecasting insights
Dr. Andree K. Bates outlines what oncology marketers need to do to ensure commercial success
Angelo DePalma explores prescription to over-the-counter (Rx to OTC) switches as a strategy for extending a product’s commercial life
Todd Johnson of Kantar Health outlines how market research can be honed into reliable data to improve forecasts
In the second of a two-part series, Dr. Andree K. Bates explores how a focus on the patient perspective and on the physician can improve patient adherence
How patients and pharma can work together—to the benefit of both
Dr. Andree Bates suggests 8 things that should be on pharma’s 2012 agenda
Rita E. Numerof argues that pharma firms should focus more on health outcomes and less on product or device features
Networking requires us to recognise that we all have something to offer
The NIH’s Undiagnosed Diseases Program (UDP) has so far discovered two new rare diseases
How online info helps to change opinions, even among physicians
Melonie Warfel, director, Life Sciences Industry Solutions, Pegasystems, on how to foster a culture of business transformation
How I learned to love the iPad a little bit less
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Peter Mansell reports on how to balance complexity and predictability when forecasting for biologics